Cancer imaging technology awarded additional FDA approval
The FDA has given additional approval to an imaging agent used to help find tumors in cancer patients, this time for those battling lung cancer. Cytalux was developed by Purdue University's Dr. Philip Low, who is also founder of On Target Laboratories Inc.... Read More